We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Siemens Healthineers - Laboratory Diagnostics

Download Mobile App

New Sensor Chip Shows Promise for Rapid, Low-Cost POC Disease Diagnostics

By LabMedica International staff writers
Posted on 27 Jun 2023
Print article
Image: LAMP reaction chamber and nanopore film sensor containing immobilized LAMP products (Photo courtesy of Texas A&M AgriLife)
Image: LAMP reaction chamber and nanopore film sensor containing immobilized LAMP products (Photo courtesy of Texas A&M AgriLife)

The Loop-Mediated Isothermal Amplification (LAMP) technique is a popular method for identifying pathogens by amplifying their DNA. The detection of LAMP-amplified products, such as the DNA of pathogens, typically requires the use of fluorescent dyes to "label" these products, which can be expensive and have low sensitivity. Now, researchers have designed a new sensor capable of diagnosing pathogens without the need for these reagents and with a high degree of sensitivity. This new development also eliminates the time-consuming process of DNA purification, which often poses challenges for point-of-care applications.

Scientists at Texas A&M AgriLife Research (College Station, TX, USA) in collaboration with Iowa State University (Ames, IA, USA) have developed a sensor chip capable of identifying numerous disease-causing pathogens with ten times the sensitivity of existing techniques. The sensor chip eliminates the need for chemical dye reagents typically employed in diagnostics. The innovative chip consists of a nanopore thin-film sensor housed within a unique reaction chamber. Uniquely designed primers are immobilized on the nanofilm, causing the amplified LAMP products to bind to the sensor. The resulting signals can then be directly and easily measured using a portable spectrometer. The sensor delivers results within approximately 30 minutes. This new technology holds the promise of rapid, inexpensive point-of-care diagnostics in various sectors, including plants, food, animals, and human health, including the detection of foodborne pathogens, bird flu, and COVID-19.

In their study, the researchers used the innovative sensor to identify Phytophthora infestans, a pathogen that causes the highly destructive late blight disease, posing a significant threat to potato and tomato crops worldwide. The LAMP chip offers a new portable platform for pathogen detection, employing label-free sensors with exceptional sensitivity. The research team will now focus on increasing its sensitivity to the subattomolar levels or even lower. They aim to overcome the existing challenges in identifying and differentiating pathogen species and strains that share high sequence similarities. The team also plans to improve detection specificity and implement quantitative detection by integrating artificial intelligence and CRISPR gene-editing technologies. Their goal is to develop a feasible product for wide-ranging use in plant, animal, and human health point-of-care applications.

“This research advances technologies that have emerged as some of our greatest opportunities for improving agriculture, food safety and human health,” said Junqi Song, Ph.D., associate professor and plant immunity research lead with AgriLife Research. “Our publication represents a step toward realizing these powerful tools against diseases.”

Related Links:
Texas A&M AgriLife Research
Iowa State University

Platinum Supplier
Automatic Nucleic Acid Workstation
Gold Supplier
Automated, Random Access Chemistry Analyzer
LIDA 300
Handheld Electrolyte Analyzer
Seamaty SE1
Filaria ELISA Test
Filaria IgG-4 ELISA Kit

Print article


Clinical Chemistry

view channel
Image: The new assays are designed to run on the B•R•A•H•M•S KRYPTOR compact PLUS clinical chemistry analyzer (Photo courtesy of Thermo Fisher)

Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia

Preeclampsia is a life-threatening blood pressure condition that can arise during pregnancy and the postpartum phase. This severe pregnancy complication is a primary cause of maternal and fetal mortality... Read more


view channel
Image: The US FDA has cleared HemoScreen point of care CBC for direct capillary sampling (Photo courtesy of PixCell Medical)

Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput

The world’s only 5-part differential Complete Blood Count (CBC) analyzer that is FDA-cleared, CE-marked, and TGA-approved for point-of-care use has now been granted FDA 510(k) clearance for direct capillary... Read more


view channel
Image: Immune cells present long before infection predict flu symptoms (Photo courtesy of Shutterstock.com)

Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms

For decades, if not centuries, scientists have struggled to solve the mystery of why certain individuals fall ill to infections while others remain unaffected. In an impressive development, researchers... Read more


view channel
Image: The rapid diagnostic test could pinpoint the correct antibiotic for infection treatment in under an hour (Photo courtesy of Microplate Dx)

Point-of-Care Device to Reduce Antibiotic Susceptibility Testing Time from Days to Minutes

Antimicrobial resistance (AMR) is a significant global health issue, currently leading to over 1.27 million deaths worldwide each year. By 2050, AMR could be causing up to 10 million deaths annually, surpassing... Read more


view channel
Image: The Tasso+ device has received CE Mark certification (Photo courtesy of Tasso)

Groundbreaking Blood Lancing Device Obtains Microliter Capillary Whole Blood Samples Painlessly

A convenient, virtually pain-free blood lancet that collects whole liquid blood samples has received CE Mark designation, making the patient-centric, high-volume blood collection solution available in... Read more


view channel
Image: A new electrochemical device can quickly and inexpensively identify people at greatest risk for osteoporosis (Photo courtesy of ACS Central Science, 2023)

Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop

With the global increase in life expectancy, the incidence of age-related conditions like osteoporosis is increasing. Osteoporosis, affecting around 200 million individuals worldwide, has a higher incidence... Read more


view channel
Image: The global fully automatic electrolyte analyzers market is projected to reach close to USD 0.77 billion by 2032 (Photo courtesy of 123RF)

Global Fully Automatic Electrolyte Analyzers Market Driven by Surge in Demand for Point-of-Care Testing

Fully automatic electrolyte analyzers can measure the levels of electrolytes in various bodily fluids like blood and plasma. Electrolytes are ions that have an electrical charge and are essential for multiple... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.